EP
TECX

Eversept Partners’s Tectonic Therapeutic TECX Stock Holding History

Eversept Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,614
Closed -$390K – 99
2022
Q1 		$390K Sell
24,614
-802
-3% -$16.6K 0.03% 83
2021
Q4 		$1.17M Sell
25,416
-4,541
-15% -$261K 0.08% 87
2021
Q3 		$2.01M Buy
+29,957
New +$2.46M 0.14% 78

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners's TECX Position: Q2 2022 in Review

Eversept Partners sold out of Tectonic Therapeutic (TECX) in Q2 2022, closing a stake of 24,614 shares — an estimated $390K sold.

Eversept Partners first reported a position in TECX in Q3 2021 and held it in 3 quarters. The position peaked at $2.01M in Q3 2021. 64 funds tracked by Wall St. Rank hold TECX as of Q2 2022.

  • Eversept Partners reported no remaining Tectonic Therapeutic position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 24,614 Tectonic Therapeutic shares in Q2 2022, an estimated $390K.
  • Eversept Partners first reported a position in Tectonic Therapeutic in Q3 2021 and held it in 3 quarters.
  • Eversept Partners's Tectonic Therapeutic position peaked at $2.01M in Q3 2021.
  • 64 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.